Targeting interstrand crosslink repair to improve chemotherapeutic strategies by Castle, L

The analysis of DNA interstrand cross-links and their repair by the modified comet assay by Castle, L, Swift, LP, McHugh, P

Nanotechnologies in food / by Chaudhry, Qasim, Castle, L., Watkins, Richard, Royal Society of Chemistry (Great Britain)

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic by Rojek, A, Dunning, J, Leliogdowicz, A, Castle, L, Van Lieshout, M, Carson, G, Sahr, F, Olliaro, P, Horby, P

Short period incidence sTudy of severe acute respiratory infection (SPRINT-SARI) initial data from a global observational study to better describe SARI epidemiology in critically i... by Carson, G, Castle, L, George, M, Horby, P, Longuere, K, Merson, L, Murthy, S, O’Neill, G, Pardinaz-Solis, R, Webb, S

Clinical assessment is a neglected component of outbreak preparedness: evidence from refugee camps in Greece by Rojek, A, Gkolfinopoulou, K, Veizis, A, Lambrou, A, Castle, L, Georgakopoulou, T, Blanchet, K, Panagiotopoulos, T, Horby, P, Epidemic Diseases Research Group field team

A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic by Rojek, A, Salam, A, Ragotte, R, Liddiard, E, Elhussain, A, Carlqvist, A, Butler, M, Kayem, N, Castle, L, Odondi, L, Stepniewska, K, Horby, P

Global outbreak research: harmony not hegemony by Akhvlediani, T, Angus, DC, Ali, SM, Lee, J, Carson, G, Denis, E, Jamieson, N, Merson, L, Moore, S, Castle, L, Horby, P, Olliaro, P, Plotkin, D, Sigfrid, L

Experimental treatment of Ebola virus disease with brincidofovir by Dunning, J, Kennedy, S, Antierens, A, Whitehead, J, Ciglenecki, I, Carson, G, Kanapathipillai, R, Castle, L, Howell-Jones, R, Pardinaz-Solis, R, Grove, J, Scott, J, Lang, T, Olliaro, P, Horby, P

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: a prospective hospital-based cohort study by Kayem, ND, Okogbenin, S, Okoeguale, J, Eigbefoh, J, Ikheloa, J, Eifediyi, R, Enodiana, X, Olorogbogo, OE, Aikpokpo, I, Ighodalo, Y, Olokor, T, Odigie, G, Castle, L, Duraffour, S, Oestereich, L, Dahal, P, Ariana, P, Gunther, S, Horby, P

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: a prospective hospital-based cohort study by Kayem, ND, Okogbenin, S, Okoeguale, J, Momoh, M, Njoku, A, Eifediyi, R, Enodiana, X, Ngwu, H, Irhiogbe, W, Ighodalo, Y, Olokor, T, Odigie, G, Castle, L, Duraffour, S, Oestereich, L, Dahal, P, Ariana, P, Gunther, S, Horby, P

Clinical characteristics of patients admitted to pneumonic plague treatment centers during the 2017 madagascar pneumonic plague outbreak: A prospective observational study by Salam, A, Raberahona, M, Rajerison, M, Andriantsalama, P, Funk, A, Castle, L, Andrianarintsiferantsoa, F, Rakotomahefa, M, Rakotoarivelo, R, Rabezanahary, H, Bertherat, E, Renaud, B, Rojek, A, Rampling, T, Denis, E, Heraud, J-M, Randrianirina, F, Baril, L, Fontanet, A, Horby, P, Randria, M, Randremanana, R

Factors influencing atypical clinical presentations during the 2017 Madagascar pneumonic plague outbreak: a prospective cohort study by Salam, AP, Raberahona, M, Andriantsalama, P, Read, L, Andrianarintsiferantsoa, F, Razafinambinintsoa, T, Rakotomalala, R, Hasiniatsy, RNE, Razafimandimby, D, Castle, L, Funk, A, Mangahasimbola, RT, Renaud, B, Bertherat, E, Lovering, A, Heraud, J-M, Andrianaivoarimanana, V, Frédérique, R, Razanajatovo, N, Baril, L, Fontanet, A, Rajerison, M, Horby, P, Randria, M, Randremanana, R

Experimental treatment of Ebola virus disease with TKM-130803: A single-arm phase 2 clinical trial. by Dunning, J, Sahr, F, Rojek, A, Gannon, F, Carson, G, Idriss, B, Massaquoi, T, Gandi, R, Joseph, S, Osman, H, Brooks, T, Simpson, A, Goodfellow, I, Thorne, L, Arias, A, Merson, L, Castle, L, Howell-Jones, R, Pardinaz-Solis, R, Hope-Gill, B, Ferri, M, Grove, J, Kowalski, M, Stepniewska, K, Lang, T, Whitehead, J, Olliaro, P, Samai, M, Horby, P

Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial by Dunning, J, Sahr, F, Rojek, A, Gannon, F, Carson, G, Idriss, B, Massaquoi, T, Gandi, R, Joseph, S, Osman, H, Brooks, T, Simpson, A, Goodfellow, I, Thorne, L, Arias, A, Merson, L, Castle, L, Howell-Jones, R, Pardinaz-Solis, R, Hope-Gill, B, Ferri, M, Grove, J, Kowalski, M, Stepniewska, K, Lang, T, Whitehead, J, Olliaro, P, Samai, M, Horby, P

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza by Wang, Y, Zhong, W, Salam, A, Tarning, J, Zhan, Q, Huang, J-A, Weng, H, Bai, C, Ren, Y, Yamada, K, Wang, D, Guo, Q, Fang, Q, Tsutomu, S, Zou, X, Li, H, Gillesen, A, Castle, L, Chen, C, Li, H, Zhen, J, Lu, B, Duan, J, Guo, L, Jiang, J, Cao, R, Fan, G, Li, J, Hayden, FG, Wang, C, Horby, P, Cao, B